Hebei Konruns Pharmaceutical Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 51,300,000 on January 18, 2019. The transaction will include participation from existing investor Beijing Konruns Pharmaceutical Co.,Ltd. (SHSE:603590).The company will add the proceeds into registered capital. On closing of the transaction, company's registered capital will increase from CNY 50,000,000 to CNY 101,300,000. The transaction has been approved at the 14th meeting of the 2nd directorate of the investor and it does not require investor's shareholders approval.